Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

20. März 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1924


	Artikel 1 - 20 / 38479

	Indocyanine green-assisted lymphography for intraoperative chyle leak prevention during esophageal cancer surgery: a systematic review of the literature. Front Oncol Puccetti F, Candiloro FS, Cinelli L, Battaglia S, Gozzini L, Elmore U, Rosati R. PMID: 41853319 [PubMed]
	Best evidence for the prevention and management of anastomotic fistula after esophagectomy in patients with esophageal cancer. Asia Pac J Oncol Nurs Liu Q, Chen X, Hong Y, Liu D. PMID: 41852756 [PubMed]
	A controlled trial comparing dosimetry and radiation pneumonitis between tomotherapy and IMRT in patients with lung or esophageal cancer. J Appl Clin Med Phys Zhang A, Zhang Y, Yang J, Chen L, Wu N, Qian J, Dai H, Yang D, Zhao L, Zhong L, Cui T, Yang F, Chen G, Gao Y, Luo W, Li G. PMID: 41850745 [PubMed - indexed for MEDLINE]
	Pretreatment Radiation Esophagitis Prediction using Quantum Machine Learning in Esophageal Cancer Patients. Int J Radiat Oncol Biol Phys Xie C, Shen Y, He J, Guo M, Mu Y, Li L, Wang W, Dou M, Zhou Y, Zhang J, Ai Y, Jin X. PMID: 41850494 [PubMed - as supplied by publisher]
	Real-world validation of the cancer dysphagia score for primary care triage of suspected upper gastrointestinal cancer referrals. Ann R Coll Surg Engl Bonomaully M, Boddy A. PMID: 41847744 [PubMed - as supplied by publisher]
	Epidemiology of Risk Stratification, Machine Learning Early Prediction Model, and Tumor Suppressive Mechanism of RHBDF2 in Esophageal Cancer in Gansu Province. Cancer Med Zhu D, Che Y, Cheng H, Wang W, Li Y. PMID: 41846261 [PubMed - indexed for MEDLINE]
	NY-ESO-1 in Triple-Negative Breast Cancer: Systematic Review, Meta-Analysis, and Immunotherapeutic Implications. Int Immunopharmacol Nik Amirah Auni NMA, Mohd Redzwan N, Hussain FA, Yahya MM, Ab Hamid SS, Wong KK. PMID: 41846058 [PubMed - as supplied by publisher]
	Clinical role of anti-PD-1 immunotherapies in esophageal cancer. Expert Rev Gastroenterol Hepatol Sano M, Imazeki H, Yamamoto S, Kato K. PMID: 41842748 [PubMed - as supplied by publisher]
	Disease Self-Monitoring Behaviors and Influencing Factors Among Family Members of Patients With Digestive Tract Cancer: A Latent Profile Analysis. Psychooncology Zhou L, Yang L, Zhu X, Han Y, Yang L, Li K. PMID: 41839757 [PubMed - indexed for MEDLINE]
	Anti-Hu paraneoplastic syndrome with gastrointestinal dysmotility associated with nasopharyngeal squamous cell carcinoma and small bowel adenocarcinoma. BMJ Case Rep Chen JN, Leung ECH, Jiang K, Cunningham JM. PMID: 41839521 [PubMed - indexed for MEDLINE]
	Comparative analysis of early-onset and late-onset esophageal cancer burden in China, 1990-2021: based on the 2021 Global Burden of Disease Study. Esophagus Zhang Z, Gong Y, Liu L, Zhu Y, Zhou J, Zhu X. PMID: 41838257 [PubMed - as supplied by publisher]
	Metformin Use and Development of Esophageal Squamous Cell Carcinoma. JAMA Netw Open Xie SH, Santoni G, Birgisson H, von Euler-Chelpin M, Kauppila JH, Ness-Jensen E, Lagergren J. PMID: 41837999 [PubMed - indexed for MEDLINE]
	Efficacy and safety of neoadjuvant immunotherapy in locally advanced resectable esophageal squamous cell carcinoma: a network meta-analysis and real-world study. Front Immunol Sun M, Yang P, Qi L, Yang T, Wang W, Yu Y, Zhang J, Zhu B, Li Y. PMID: 41836437 [PubMed - indexed for MEDLINE]
	Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysis. Front Immunol Yang K, Shang W, Wang L, He J, Zuo Z, Dai Q, Liu J, Zeng L, Yang Y, Cao F, Yu Y, Wan G. PMID: 41836421 [PubMed - indexed for MEDLINE]
	Surgical treatment of the patient with locally advanced esophageal cancer and concurrent thymoma after neoadjuvant therapy: a case report. Front Immunol Zhang QX, Liu H, Xu J, Zeng T, Zhang J, Ren XF, Li D, Guo Q, Liu T. PMID: 41836409 [PubMed - indexed for MEDLINE]
	A combined immune-nutritional score as a prognostic indicator in neoadjuvant-treated esophageal squamous cell carcinoma. Front Immunol Xie Q, Zhan J, Ye X, Huang C, Chen C, Zheng B, Xu G, Yang Z, Zhu Y. PMID: 41836385 [PubMed - indexed for MEDLINE]
	Study on the network of postoperative symptoms and its influencing factors in esophageal cancer patients. Front Oncol Zhao J, Liu Y, Xiao B, Tan T, Yin Y, Hu Y, Li L. PMID: 41836233 [PubMed]
	Mutant p53 and TP53 mutations in esophageal squamous cell carcinoma: consistency and diagnostic significance. Front Genet Zhuang X, Lin N, Xu Y. PMID: 41836060 [PubMed]
	Menopausal hormone therapy and risk of esophageal and gastric cancer in a multi-national study. J Natl Cancer Inst Wocalewski V, Santoni G, Birgisson H, Von Euler-Chelpin M, Kauppila JH, Ness-Jensen E, Xie S, Lagergren J. PMID: 41834112 [PubMed - as supplied by publisher]
	Cancer Stem Cells in Esophageal Squamous Cell Carcinoma: A Path to Understanding. Curr Stem Cell Res Ther Singhal D, Saini M, Ghosal S, Sengupta U, Bhaumik C, Kashyap M, Krishnia L, Kashyap MK. PMID: 41830565 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 38479

Seite 1 von 1924



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung